IMS Health Holdings (IMS) has risen sharply, recording gains of 8.13% in the past 4 weeks. However, the stock has corrected -0.3% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 5.5% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.
IMS Health Holdings (NYSE:IMS): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $29.76 and $29.76 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $30.17. The buying momentum continued till the end and the stock did not give up its gains. It closed at $29.93, notching a gain of 0.54% for the day. The total traded volume was 832,981 . The stock had closed at $29.77 on the previous day.
The stock has recorded a 20-day Moving Average of 4.26% and the 50-Day Moving Average is 11.93%. IMS Health Holdings, Inc. is up 20.83% in the last 3-month period. Year-to-Date the stock performance stands at 17.51%.
IMS Health Holdings (IMS) : 8 Wall Street analysts covering IMS Health Holdings (IMS) believe that the average level the stock could reach for the short term is $32.88. The maximum price target given is $38 and the minimum target for short term is around $28, hence the standard deviation is calculated at $2.9.
IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Companys principal offerings include national information offerings, sub-national information offerings, workflow analytics, real-world evidence (RWE) solutions, technology and applications and clinical solutions.